• For Researchers

Coming together for Zynlonta

How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma. How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma.

2 July 2021

• For Researchers

A bug in the system – the difficulties of linking the microbiome to cancer aetiology

Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome. Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome.

2 June 2021

• For Researchers

Cancer clinical trials – learning lessons from the COVID-19 pandemic

After a very difficult year for cancer clinical trials, we look to the future and ask what positive lessons can be learnt After a very difficult year for cancer clinical trials, we look to the future and ask what positive lessons can be learnt

20 May 2021

• For Researchers

Mitochondrial DNA in cancer: small genome, big impact

Payam Gammage believes understanding the mutations in mtDNA could reveal indicators of cancer prognosis and a new focus for therapeutics. Payam Gammage believes understanding the mutations in mtDNA could reveal indicators of cancer prognosis and a new focus for therapeutics.

5 May 2021

• For Researchers

Digging for early detection success in our sandpit workshops

Our sandpit workshops bring together researchers from different disciplines to develop research ideas for the early detection of cancer. Our sandpit workshops bring together researchers from different disciplines to develop research ideas for the early detection of cancer.

13 April 2021

• For Researchers

How UK researchers commercialised CD25 as an immunotherapy drug target

Cancer Research UK scientists in collaboration with Roche have developed a new antibody that can target CD25 and harness the immune system against cancer. Cancer Research UK scientists in collaboration with Roche have developed a new antibody that can target CD25 and harness the immune system against cancer.

12 April 2021

• For Researchers

The journey to patient avatars: building a living biobank for ovarian cancer

In the search for new treatments for high-grade serous ovarian carcinoma, one Cancer Research-UK funded team built a living biobank. In the search for new treatments for high-grade serous ovarian carcinoma, one Cancer Research-UK funded team built a living biobank.

26 March 2021

• For Researchers

New research explores aneuploidy in children’s and young people’s cancers

We’re supporting new research exploring aneuploidy as a driver of children’s and young people’s cancer and a target for novel therapies. We’re supporting new research exploring aneuploidy as a driver of children’s and young people’s cancer and a target for novel therapies.

18 March 2021

• For Researchers

How our Women of Influence programme sets scientists up for success

We spoke to three Women of Influence participants – a mentor and her two mentees – about their experiences of being involved in the initiative. We spoke to three Women of Influence participants – a mentor and her two mentees – about their experiences of being involved in the initiative.

8 March 2021

• For Researchers

Examining equality in our grant giving

As we share diversity data on how we fund research, we invite our researchers and other leading voices in EDI to give us their view. As we share diversity data on how we fund research, we invite our researchers and other leading voices in EDI to give us their view.

25 February 2021

• For Researchers

Changes to Cancer Research UK's peer review process for grant applications

We're changing our peer review process for grants, reducing the emphasis on written peer reviews and instead focusing on expert review panels. We're changing our peer review process for grants, reducing the emphasis on written peer reviews and instead focusing on expert review panels.

4 February 2021

• For Researchers

2021: A bright future for cancer research

Despite a difficult 2020, there is a lot to be excited about for cancer research in 2021. Three experts tell us how progress is changing the research landscape. Despite a difficult 2020, there is a lot to be excited about for cancer research in 2021. Three experts tell us how progress is changing the research landscape.

28 January 2021